[ad_1]
Fish oil, vitamin D, new drugs and new cholesterol guidelines – News about research that does not combine heart attacks and other problems at meetings of the American Heart Association (AHA) and the American College of Cardiology.
As announced this week, the good news at this meeting is that Americans do not have to starve to at least a blood test for cholesterol testing. It is okay for most people to have something to eat. Before taking blood for analysis.
Read more:A pressure regulating cellar
Physicians have recommended natural foods and balanced nutrition as the basis for their health and concluded adding vitamins or minerals tablets only when not enough. "Nutritional supplements" are mostly missed. , But not by their own hand, but only by the physician's recommendation, only to the patient in need, individually.
In any case, they said, "As supplements do," said Dr. Penny Kris-Eterton, a researcher at the University of Pennsylvania, "they are supplements," rather than replacing vitamins and minerals, the best basic foods for health.
Read more: The stomach relieves the stomach.
So, for example, at the meeting, doctors once again see that vitamin D is a "supplement" instead of twice as much fat as a fish, or at least a study of heart disease needs better fish oil than supplements I did.
The conclusions and other conclusions approved at this meeting were attended by authors and doctors, none of which are financially relevant to pharmaceutical companies, the AP reported.
Two large-scale studies published at this conference have produced mixed results for fish oil or "omega-3 fatty acids." There are other types, including EPA and DHA.
In a study of 26,000 healthy people, a combination of EPA / DHA 1 gram per day, a dose and a type of dietary supplement "supplements" did not show a definite possibility of reducing the risk of heart or cancer problems.
However, another study that tested 4 grams of concentrated EPA per day showed that high triglycerides, one of the bloody fats, reduced heart disease among people at high risk.
The first study of the effects of small amounts of fish oil on the general population included the effects of vitamin D, one of the most common "supplements", and found that it did not reduce the risk of cancer or heart disease.
"We have to accept that this test is good," said Dr. Jane Armitage of the University of Oxford in the UK. "Vitamin D is not a worthy supplement." "We have no gain from him."
Dr Dipak Bat of Boston Women's Hospital does not throw away money for "poorly controlled and different quality" additives.
All of this is stated in the guidelines of the Heart Association and the American College of Cardiology and has been approved by other physician groups.
A new guideline for calculating cholesterol levels at multi-dimensional meetings on heart disease, the leading cause of death worldwide, results in arterial damage leading to a heart or stroke.
Five years ago, when guidelines for determining cures for cholesterol reduction were revised last time, it was decided who needed more than just a single number for cholesterol levels. It began with a formula to consider age, hypertension, and other factors to expand the risk assessment.
This confused doctors and, according to the newly established guidelines at last week's meeting, the two approaches were combined to formulate a formula-based goal and establish a personal "personal situation" for each patient, such as a family history of other health conditions or early history, Considered the heart.
"Cholesterol levels are never going to be simple," said Dr. Donald Lloyd-Johnson of the University of Northwestern.
If treatment is needed, the doctor's first choice remains "statin", which is sold as cheap generic medicines. For people at high risk, such as those already suffering from heart attacks, it is advisable to add other generic medicines without "cholesterol" being sufficiently reduced with statins. It is also called "cheap formulation". Only if the two drugs are not helpful enough, you should consider a powerful but expensive new drug called the "PCSK9 inhibitor".
Finally, if you are not sure whether you will need the treatment after all the analysis in the guidelines is complete, a coronary calcium test should be performed, which is a type of X-ray examination with similar radiation dose to mammography, The review costs $ 100 to $ 300, so it is too expensive.
At a conference of the American Heart Association, a relatively new drug approved this year not only helped control blood sugar and weight loss in diabetics, but also confirmed the need for hospitalization for heart failure. The case is followed by diabetes.
If a diabetic patient suffers heart disease, the new diabetic drug should be screened to show that it is not dangerous to the heart in large-scale studies.
One such drug, the generic empagliflozin, surprised physicians by reducing the risk of heart and stroke years ago, but another common kanagliflozin later had side effects.
The study, published this week at the American Association of American Society after a meeting of the American Heart Association and the American College of Cardiology, found that other cardiac risk factors 17,000 people with low-rate diabetes have tested the third drug, generic daplegiflozine.
[ad_2]
Source link
